Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

By Dell'Agnello Grazia  

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 739-753

Adis International

Access to resources Recommend Favorite

Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine

By Ramos-Quiroga Josep   Corominas-Roso Margarida   Palomar Gloria   Gomez-Barros Nuria   Ribases Marta   Sanchez-Mora Cristina   Bosch Rosa   Nogueira Mariana   Corrales Montserrat   Valero Sergi   Casas Miguel  

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1389-1395

Springer Publishing Company

Access to resources Recommend Favorite

There is strong support for the use of methylphenidate to treat adults with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite